DE69715014D1 - Glycolipid-komplexe und ihre anwendung. - Google Patents

Glycolipid-komplexe und ihre anwendung.

Info

Publication number
DE69715014D1
DE69715014D1 DE69715014T DE69715014T DE69715014D1 DE 69715014 D1 DE69715014 D1 DE 69715014D1 DE 69715014 T DE69715014 T DE 69715014T DE 69715014 T DE69715014 T DE 69715014T DE 69715014 D1 DE69715014 D1 DE 69715014D1
Authority
DE
Germany
Prior art keywords
glycolipid
complex
diagnostic methods
glycolipid complexes
sulfatide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715014T
Other languages
English (en)
Other versions
DE69715014T2 (de
Inventor
Karsten Buschard
Pam Fredman
Jan-Eric Mansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ SCIENCE AB (PUBL), GOETEBORG, SE
Original Assignee
A+ Science Invest AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB filed Critical A+ Science Invest AB
Publication of DE69715014D1 publication Critical patent/DE69715014D1/de
Application granted granted Critical
Publication of DE69715014T2 publication Critical patent/DE69715014T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69715014T 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung. Expired - Fee Related DE69715014T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses
SE9601817 1996-05-13
PCT/SE1997/000769 WO1997042974A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses

Publications (2)

Publication Number Publication Date
DE69715014D1 true DE69715014D1 (de) 2002-10-02
DE69715014T2 DE69715014T2 (de) 2004-02-26

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715014T Expired - Fee Related DE69715014T2 (de) 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung.

Country Status (13)

Country Link
US (2) US6352831B1 (de)
EP (1) EP0928201B1 (de)
JP (1) JP2000513332A (de)
AT (1) ATE222775T1 (de)
AU (1) AU728141B2 (de)
CA (1) CA2253883A1 (de)
DE (1) DE69715014T2 (de)
DK (1) DK0928201T3 (de)
ES (1) ES2183177T3 (de)
HK (1) HK1021321A1 (de)
PT (1) PT928201E (de)
SE (1) SE9601817D0 (de)
WO (1) WO1997042974A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049477A1 (de) 1997-12-30 2000-11-08 A+ Science Invest AB Galactosylceramide, glucosylceramide, lactosylceramide, und spezifische fänger für diese zur verwendung in der prophylaxe oder therapie der prädiabetes, diabetes und/oder damit zusammenhängender komplikationen
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
JP2009510124A (ja) * 2005-09-29 2009-03-12 トーリー パインズ インスティチュート フォー モルキュラー スタディーズ 自己免疫障害の治療のためのスルファチド
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
CA2150956A1 (en) 1992-12-10 1994-06-23 Robert G. L. Shorr Glycolipid enzyme-polymer conjugates

Also Published As

Publication number Publication date
PT928201E (pt) 2003-01-31
EP0928201A1 (de) 1999-07-14
AU2918897A (en) 1997-12-05
JP2000513332A (ja) 2000-10-10
US20020034769A1 (en) 2002-03-21
AU728141B2 (en) 2001-01-04
HK1021321A1 (en) 2000-06-09
US6352831B1 (en) 2002-03-05
EP0928201B1 (de) 2002-08-28
ATE222775T1 (de) 2002-09-15
ES2183177T3 (es) 2003-03-16
CA2253883A1 (en) 1997-11-20
DK0928201T3 (da) 2002-12-23
SE9601817D0 (sv) 1996-05-13
DE69715014T2 (de) 2004-02-26
WO1997042974A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
GB1498081A (en) Covalently bound biological substances to plastic materials and use in radioassay
TR199701547T1 (xx) Polisakarit antijen protein e�leni�i i�eren a��.
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
ES2013226A4 (es) Metodo y composiciones proveiendo quimicoluminiscencia mejorada de 1,2-dioxanos
ATE138257T1 (de) Kompressionsbandage mit normungsmittel
DE69128152D1 (de) Synthetische peptide von menschlichen papillomaviren 1, 6, 11, 16, 18, 31, 33 und 56, die nützlich in immunoassays für diagnostische zwecke sind
SE8502574L (sv) Forfarande for tverbindning av en poros polysackaridgel
DE69004260D1 (de) Filtervorrichtung, insbesondere für die ansaugluft von brennkraftmaschinen.
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
DE69715014D1 (de) Glycolipid-komplexe und ihre anwendung.
ATE69891T1 (de) Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
FI894804A0 (fi) Anvaendning av zink- och jaernhydroxid som adjuvanter av antigenloesningar och pao detta saett effektiverade antigenloesningar.
AU4032095A (en) Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof
JPS57122054A (en) Tridecapeptide and manufacture
DK152506C (da) Geldannende polysakkarid, fremgangsmaade til dets fremstilling og anvendelse af det
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
DE3670632D1 (de) Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
IE40645L (en) Preparations for detecting treponemal diseases such as¹syphilis comprising an antigen reagent and an azo dye.
DE19780326T1 (de) Verbesserungen im Hinblick auf die Herstellung von Antikörpern, Test-Kits mit Antikörpern und medizinische Anwendung mit Antikörpern
FI861715A (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DE69006563D1 (de) Befeuchtigungsvorrichtung für Gegenstände, als Teil einer Einrichtung und ihre Anwendung.
CA2202913A1 (en) Antibody reagent for detecting dissecting aortic aneurysm and uses thereof
AU647449B2 (en) Method for the immunological determination of ligands
KR860008779A (ko) 항체 형성 화합물의 제조방법

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: A+ SCIENCE AB (PUBL), GOETEBORG, SE

8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee